Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the efficacy and safety of Pletaal (Cilostazol)
in comparison with placebo for 4 weeks in vasospastic angina patients who have an
insufficient response to Amlodipine (Calcium channel blocker).